Abstract:Objective The inhibitor of differentiation 3 (Id3) is an important transcriptional regulation factor, which participates in tumorigenesis, cell proliferation, and cell apoptosis.β-catenin, as a central molecule of the Wnt signaling pathway, is critical for tumor development.This study aimed to evaluate the expressions of these two molecules and the regulatory effect of Id3 on β-catenin in different tumor cells.Methods Total RNA was extracted using the Trizol Reagent.The relative mRNA expression levels of Id3 and β-catenin in tumor cells were detected by quantitative real-timePCR(qRT-PCR).The recombinant eukaryotic expression vector pEGFP/Id3 with the human Id3 gene was transfected into A549, A549/ DDP and SW-480 cells using the non-liposome-mediated method.The protein expressions of Id3 and β-catenin were determined by Western blot.Results The expression of Id3 was significantly lower in the colorectal cancer cell lines SW-480 and HT-29 than in A549 and other tumor cells (P<0.05), but remarkably higher in nasopharyngeal carcinoma CNE and 5-8F cells than in other tumor cells (P<0.05).The expression of β-catenin was the highest in SW-480in comparison withother malignant tumor cells(P<0.05), and the second highest was in gastric cancer AGS and colorectal cancer HT-29 cell lines, but low in H446, A549, SPC-A-1, A549/DDP, and SK-MES-1 cell lines and extremely low or almost absent in CNE and 5-8F cells (P<0.05).After transfected with pEGFP/Id3, the cells showed a decreased volume, wrinkled membrane and absent refraction under the fluorescence microscope, which, however, were not observed in most of the cells transfected with the empty vector pEGFP.Compared with the control, the Id3/pEGFP group showed remarkably increased expressions of Id3 mRNA in the A549, A549/DDI, and SW-480 cells (1.24±0.12 vs 193.12±2.80, 1.09±0.11 vs 188.30±2.60, and 0.92±0.29 vs 19.08±0.59, P<0.01), and the expression of β-catenin was significantly down-regulated in the transfected SW-480 cells with an overexpression of Id3 (0.98±0.05 vs 0.32±0.03, P<0.01), but exhibited no statistically significant differences from those in the transfected A549 and A549/DDP cells (0.98±0.07 vs 1.04±0.08 and 0.98±0.05 vs 0.32±0.03, P>0.05).Western blot showed the same results.Conclusion The expression levels of Id3 and β-catenin vary in different tumor cell lines.Anabnormally high level of β-catenin is an important risk factor for colorectal cancer, and the down-regulatedexpression of β-catenin after eogenous transfection of Id3 may provide some new ideas for target gene therapies of colorectal cancer.

Id 2 Predicts Poor Prognosis in Breast Cancer , Especially in Triple-Negative Breast Cancer , and Inhibits E-Cadherin Expression

ID2 Inhibits Bladder Cancer Progression and Metastasis via PI3K/AKT Signaling Pathway

Biomarker Discovery To Improve Prediction Of Breast Cancer Survival: Using Gene Expression Profiling, Meta-Analysis, And Tissue Validation

DEPTOR Stabilizes ErbB2 to Promote the Proliferation and Survival of ErbB2-positive Breast Cancer Cells.

Elevated CISD2 Expression Predicts Poor Diagnosis and Promotes Invasion and Migration of Prostate Cancer Cells.

Expression and prognostic value of Id protein family in human breast carcinoma

Id2-Dependent Anti-Tumor Immunity Promotes Anti-Cancer Therapies Effects

Expressions of Progesterone Receptor a and B in Breast Invasive Ductal Carcinoma and Their Clinical Significance

Outcome Prediction Values of Soluble Human Epidermal Growth Factor Receptor-2 Extracellular Domain in Metastatic Breast Cancer

EHD2 is a Predictive Biomarker of Chemotherapy Efficacy in Triple Negative Breast Carcinoma

Dominant-negative E-cadherin inhibits the invasiveness of inflammatory breast cancer cells in vitro

Prediction Of Recurrence Risk In Early Breast Cancer Using Human Epidermal Growth Factor 2 And Cyclin A2

EHD2 Inhibits the Invasive Ability of Lung Adenocarcinoma and Improves the Prognosis of Patients

PDSS2 Promotes Epithelial-Mesenchymal Transition and Angiogenesis in Breast Cancer Cells by Activating the NF-KB Pathway

ID2 promotes tumor progression and metastasis in thyroid cancer

Regulatory effect of overexpressed Id3 on the expression of β-catenin in different tumor cells

DPM2 serve as novel oncogene and prognostic marker transactivated by ESR1 in breast cancer

Expression of E-cadherin, Beta-Catenin, Cathepsin D, Gelatinases and Their Inhibitors in Invasive Ductal Breast Carcinomas

ITM2A as a Tumor Suppressor and Its Correlation With PD-L1 in Breast Cancer

A Novel Role of Id-1 in Regulation of Epithelial-to-mesenchymal Transition in Bladder Cancer.

Inhibitor of DNA Binding 3 Reverses Cisplatin Resistance in Human Lung Adenocarcinoma Cells by Regulating the PI3K/Akt Pathway.